AMRX
Amneal Pharmaceuticals, Inc. Class A Common Stock
NASDAQ: AMRX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$12.78
+1.70% today
Updated 2026-06-05
Market cap
$5.17B
P/E ratio
43.78
P/S ratio
1.70x
EPS (TTM)
$0.37
Dividend yield
—
52W range
$8 – $17
Volume
1.5M
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$12.78
12-Month target
$6.77
2030 Target
—
Intrinsic (DCF)
$22.32
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $2.1B | $2.2B | $2.4B | $2.8B | $3.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 4.01%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.